Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Inventory Average (2022 - 2023)

Amylyx Pharmaceuticals (AMLX) has 2 years of Inventory Average data on record, last reported at $35.3 million in Q4 2023.

  • For Q4 2023, Inventory Average rose 584.25% year-over-year to $35.3 million; the TTM value through Dec 2023 reached $35.3 million, up 584.25%, while the annual FY2023 figure was $24.0 million, N/A changed from the prior year.
  • Inventory Average reached $35.3 million in Q4 2023 per AMLX's latest filing, up from $28.6 million in the prior quarter.
  • Across five years, Inventory Average topped out at $35.3 million in Q4 2023 and bottomed at $5.2 million in Q4 2022.